These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4970532)

  • 1. Intracellular distribution of hepatic carbonic anhydrase in mice bearing Ehrlich ascites carcinoma or with spontaneous mammary carcinoma.
    Suzuki S; Ogawa E
    Gunma J Med Sci; 1967 Mar; 16(1):74-8. PubMed ID: 4970532
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic arginase activity in mice bearing Ehrlich ascites carcinoma.
    Abreu LA; Abreu RR
    Arch Geschwulstforsch; 1968; 31(1):1-4. PubMed ID: 5674790
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on liver glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase of Ehrlich ascites tumor-bearing mice (author's transl)].
    Asanami S
    Shikwa Gakuho; 1979 Feb; 79(2):361-8. PubMed ID: 298052
    [No Abstract]   [Full Text] [Related]  

  • 4. Study on tyrosine: 2-oxoglutarate aminotransferase activity in the liver of tumor-bearing and injured mice.
    Oka Y
    Nagoya J Med Sci; 1971 Jun; 34(1):1-11. PubMed ID: 5113240
    [No Abstract]   [Full Text] [Related]  

  • 5. Proteolytic activity in liver cells from mouse, rat, Ehrlich ascites carcinoma bearing mouse and in Ehrlich ascites carcinoma cells.
    Tekavcic E; Skrk J; Suhar A; Lebez D
    Neoplasma; 1976; 23(5):515-22. PubMed ID: 10531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an alkylating agent on liver arginase in normal and Ehrlich carcinoma bearing mice.
    Abreu RR; Abreu LA
    Hospital (Rio J); 1969 Jul; 76(1):345-51. PubMed ID: 5307536
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic administration of caffeine: effect on the activities of hepatic antioxidant enzymes of Ehrlich ascites tumor-bearing mice.
    Mukhopadhyay S; Mondal A; Poddar MK
    Indian J Exp Biol; 2003 Apr; 41(4):283-9. PubMed ID: 15255635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminant responses of the catalytic unit and glucose 6-phosphate transporter components of the hepatic glucose-6-phosphatase system in Ehrlich ascites-tumor-bearing mice.
    Foster JD; Wiedemann JM; Pan CJ; Chou JY; Nordlie RC
    Arch Biochem Biophys; 2001 Sep; 393(1):117-22. PubMed ID: 11516168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal calf serum and epidermal growth factor prevent the inhibitory action of a chalone-like growth inhibitor for Ehrlich ascites mammary carcinoma cells in vitro.
    Lehmann W; Graetz H; Widmayer R; Langen P
    Biomed Biochim Acta; 1984; 43(7):971-4. PubMed ID: 6240265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of lactate dehydrogenase in Ehrlich Ascites cells & host's liver.
    Dohadwala MM; Datta AG; Chaudhuri L
    Indian J Biochem Biophys; 1980 Jun; 17(3):191-3. PubMed ID: 7450804
    [No Abstract]   [Full Text] [Related]  

  • 11. [Disorders in metabolism of superoxide radicals in tumor-bearing mice during development of Ehrlich ascites carcinoma and their normalization under the effect of ruboxyl].
    Gurevish SM; Vartanian LS; Nagler LG
    Vopr Med Khim; 1993; 39(6):16-20. PubMed ID: 8303863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On a "chalone"-like factor for Ehrlich ascites mammary carcinoma.
    Lehmann W; Graetz H; Samtleben R; Schütt M; Langen P
    Acta Biol Med Ger; 1980; 39(1):93-105. PubMed ID: 6448529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors elevating liver tyrosine: 2-oxoglutarate aminotransferase activity in tumor-bearing mice.
    Kato Y
    Nagoya J Med Sci; 1967 Sep; 30(2):211-23. PubMed ID: 4384080
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in lipoprotein lipase activity (LPLA) in tumor cells and tissues in mice bearing Ehrlich ascites tumor.
    Bálint Z; Holczinger L
    Bull Cancer; 1984; 71(5):412-8. PubMed ID: 6525466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiamine metabolism in the liver of mice with Ehrlich ascites carcinoma.
    Trebukhina RV; Ostrovsky YuM ; Shapot VS; Petushok VG; Velichko MG; Tumanov VN; Mikhaltsevich GN
    Neoplasma; 1982; 29(3):257-68. PubMed ID: 6127634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on liver arginase in mice with Ehrlich carcinoma.
    Abreu LA; Abreu RR
    Hospital (Rio J); 1968 Apr; 73(4):1287-90. PubMed ID: 5307510
    [No Abstract]   [Full Text] [Related]  

  • 17. Transitions of hepatic purine metabolism of Ehrlich ascites tumor bearing mice in different phases of tumor growth.
    Schwendel A; Siems WG; Grune T; Holzhütter HG
    Biochem Mol Biol Int; 1994 Oct; 34(3):457-63. PubMed ID: 7833823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular distribution of inorganic pyrophosphatase activity in various normal and neoplastic cell types.
    Shatton JB; Williams A; Weinhouse S
    Cancer Res; 1983 Aug; 43(8):3742-7. PubMed ID: 6134580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of folylderivative biosynthesis in Ehrlich ascites carcinoma cells and in some organs of healthy and tumor-bearing mice.
    Sikora E; Grzelakowska-Sztabert B
    Neoplasma; 1984; 31(2):139-48. PubMed ID: 6717683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is ribonucleotide reductase in Ehrlich ascites mammary tumour cells the target of a growth inhibitor purified from bovine mammary gland?
    Langen P; Lehmann W; Graetz H; Böhmer FD; Grosse R
    Biomed Biochim Acta; 1984; 43(12):1377-83. PubMed ID: 6398699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.